A citation-based method for searching scientific literature

John H Krystal, Chadi G Abdallah, Gerard Sanacora, Dennis S Charney, Ronald S Duman. Neuron 2019
Times Cited: 134



P Zanos, T D Gould. Mol Psychiatry 2018
Times Cited: 327




List of shared articles



Times cited

Intranasal esketamine and the dawn of precision psychiatry.
Devon Watts, Frederico D Garcia, Acioly L T Lacerda, Jair de J Mari, Lucas C Quarantini, Flávio Kapczinski. Braz J Psychiatry 2022
1

Rapid-acting antidepressants and the circadian clock.
Shogo Sato, Blynn Bunney, Lucia Mendoza-Viveros, William Bunney, Emiliana Borrelli, Paolo Sassone-Corsi, Ricardo Orozco-Solis. Neuropsychopharmacology 2022
2


Glutamatergic receptor and neuroplasticity in depression: Implications for ketamine and rapastinel as the rapid-acting antidepressants.
Ya-Ting Wang, Ning-Ning Zhang, Ling-Jie Liu, Hong Jiang, Die Hu, Zhen-Zhen Wang, Nai-Hong Chen, Yi Zhang. Biochem Biophys Res Commun 2022
0

Is (R)-ketamine a potential therapeutic agent for treatment-resistant depression with less detrimental side effects? A review of molecular mechanisms underlying ketamine and its enantiomers.
Ellen Scotton, Bárbara Antqueviezc, Mailton França de Vasconcelos, Giovana Dalpiaz, Luiza Paul Géa, Jéferson Ferraz Goularte, Rafael Colombo, Adriane Ribeiro Rosa. Biochem Pharmacol 2022
1

New Insights Into the Pivotal Role of CREB-Regulated Transcription Coactivator 1 in Depression and Comorbid Obesity.
Clara Rossetti, Antoine Cherix, Laetitia F Guiraud, Jean-René Cardinaux. Front Mol Neurosci 2022
0

Ketamine as a Novel Psychopharmacotherapy for Eating Disorders: Evidence and Future Directions.
Anya Ragnhildstveit, Matthew Slayton, Laura Kate Jackson, Madeline Brendle, Sachin Ahuja, Willis Holle, Claire Moore, Kellie Sollars, Paul Seli, Reid Robison. Brain Sci 2022
0

Ketamine exerts its sustained antidepressant effects via cell-type-specific regulation of Kcnq2.
Juan Pablo Lopez, Malte D Lücken, Elena Brivio, Stoyo Karamihalev, Aron Kos, Carlo De Donno, Asaf Benjamin, Huanqing Yang, Alec L W Dick, Rainer Stoffel,[...]. Neuron 2022
0

Blood-based biomarkers of antidepressant response to ketamine and esketamine: A systematic review and meta-analysis.
Gustavo C Medeiros, Todd D Gould, William L Prueitt, Julie Nanavati, Michael F Grunebaum, Nuri B Farber, Balwinder Singh, Sudhakar Selvaraj, Rodrigo Machado-Vieira, Eric D Achtyes,[...]. Mol Psychiatry 2022
0

Uncovering the Underlying Mechanisms of Ketamine as a Novel Antidepressant.
Songbai Xu, Xiaoxiao Yao, Bingjin Li, Ranji Cui, Cuilin Zhu, Yao Wang, Wei Yang. Front Pharmacol 2022
0

Reproducing the dopamine pathophysiology of schizophrenia and approaches to ameliorate it: a translational imaging study with ketamine.
Michelle Kokkinou, Elaine E Irvine, David R Bonsall, Sridhar Natesan, Lisa A Wells, Mark Smith, Justyna Glegola, Eleanor J Paul, Kyoko Tossell, Mattia Veronese,[...]. Mol Psychiatry 2021
20

The Effects of Ketamine on Cognition in Treatment-Resistant Depression: A Systematic Review and Priority Avenues for Future Research.
Hartej Gill, Barjot Gill, Nelson B Rodrigues, Orly Lipsitz, Joshua Daniel Rosenblat, Sabine El-Halabi, Flora Nasri, Rodrigo B Mansur, Yena Lee, Roger S McIntyre. Neurosci Biobehav Rev 2021
14

The Antidepressant-Like Effects of a Clinically Relevant Dose of Ketamine Are Accompanied by Biphasic Alterations in Working Memory in the Wistar Kyoto Rat Model of Depression.
Conor W McDonnell, Fionn Dunphy-Doherty, Jennifer Rouine, Massimiliano Bianchi, Neil Upton, Ewa Sokolowska, Jack A Prenderville. Front Psychiatry 2021
2

Antidepressant Actions of Ketamine: Potential Role of L-Type Calcium Channels.
Bonnie Robinson, Qiang Gu, Jyotshna Kanungo. Chem Res Toxicol 2021
1

Ketamine Rapidly Enhances Glutamate-Evoked Dendritic Spinogenesis in Medial Prefrontal Cortex Through Dopaminergic Mechanisms.
Mingzheng Wu, Samuel Minkowicz, Vasin Dumrongprechachan, Pauline Hamilton, Yevgenia Kozorovitskiy. Biol Psychiatry 2021
22

Repeated but Not Single Administration of Ketamine Prolongs Increases of the Firing Activity of Norepinephrine and Dopamine Neurons.
Chidiebere M Iro, Rami Hamati, Mostafa El Mansari, Pierre Blier. Int J Neuropsychopharmacol 2021
1

The NEO-FFI domain of openness to experience moderates ketamine response in treatment resistant depression.
Roman M Dale, Kelly A Bryant, Nora Finnegan, Kim Cromer, Nicolas R Thompson, Murat Altinay, Amit Anand. J Affect Disord 2020
4

Metabolic Syndrome Rather Than Body Mass Index Is Associated With Treatment Response to Ketamine Infusions.
Roman M Dale, Kelly A Bryant, Nicolas R Thompson. J Clin Psychopharmacol 2020
10